Mar 14, 2023 / 02:15PM GMT
Balaji V. Prasad - Barclays Bank PLC, Research Division - Director
Good morning, everyone. My name is Balaji Prasad. I'm the senior analyst for the Barclays Specialty Pharmaceuticals coverage. For the next session of the day at the Barclays Annual Healthcare Conference, I have the pleasure of hosting Teva and Eli Kalif, the Chief Financial Officer from Teva. Eli, thank you so much for joining us today. It's a pleasure to have you here.
Eliyahu Sharon Kalif - Teva Pharmaceutical Industries Limited - Executive VP & CFO
Thank you for having me. Really excited to be here.
Balaji V. Prasad - Barclays Bank PLC, Research Division - Director
Yes. It's a very interesting phase for Teva now with the CEO change and everything else. But considering that you had your earnings call recently, why don't you start with a couple of recaps from the earnings call and then we can get into Q&A.
Eliyahu Sharon Kalif - Teva Pharmaceutical Industries Limited - Executive VP & CFO
Yes. So
Teva Pharmaceutical Industries Ltd at Barclays Global Healthcare Conference Transcript
Feb 11, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers